CASP7 and breast cancer: Kaplan–Meier survival curves for relapse-free survival indicated a better prognosis with higher expression of CASP7 in patients with combinatorial endocrine therapy and no survival significance in patients treated exclusively with tamoxifen or in ER-negative BC patients.